INSTITUTIONAL AND LEGAL GAPS IN MEDICINAL PLANT GOVERNANCE: EVIDENCE FROM UZBEKISTAN’S POST-2020 REFORM CYCLE

Authors

  • Rustamov Mukhammadrizo Rustam ogli¹, ¹Master’s Student, Central Asian University of Environmental Studies and Climate Change (Green University), Tashkent, Author
  • Abdullaev Fayzulla Khabibullaevich² ²Researcher, “Center for Innovation and Technology Implementation” LLC, PhD, Author

Keywords:

medicinal plants; institutional reform; Uzbekistan; quota governance; GACP; sustainable use; legal framework; environmental law.

Abstract

This paper evaluates the institutional and legal framework governing medicinal and aromatic plant (MAP) conservation and sustainable use in Uzbekistan, focusing on the reform cycle initiated by Presidential Decree PP-4901 (2020) and extended through PQ-251 (2022), PF-14 (2023), and PF-149 (2024). Drawing on primary regulatory documents, harvest quota data, and comparative legal analysis, the study identifies four structural deficiencies: the absence of a consolidated sector-specific law; fragmented inter-agency competence across four ministries with no formal coordination protocol; methodologically inadequate quota-setting relying on administrative norms rather than field-verified stock inventories; and the absence of internationally accredited quality testing infrastructure. Quota analysis across ten priority species reveals that state allocations cover only 40–63% of documented market demand, generating structural incentives for illegal wild-harvesting. A cost-benefit analysis yields a benefit-cost ratio of 11:1 to 18:1 for the proposed reform package, with a ten-year net present value of USD 84.9–156.7 million at a 10% discount rate.

References

1.S. Zamani, M. Fathi, M.-T. Ebadi, and Á. Máthé, "Global trade of medicinal and aromatic plants: A review," Journal of Agriculture and Food Research, vol. 21, p. 101910, 2025.

2.EastFruit Market Intelligence, Medicinal Plant Market: Uzbekistan and Central Asia, Kyiv: EastFruit Analytics, 2023.

3. Ministry of Ecology, Environmental Protection and Climate Change of the Republic of Uzbekistan, Official Statistics on Illegal Flora Collection, January–September 2023, Tashkent: MoECC, 2023.

4.Presidential Decree No. PP-4901 of 26 November 2020 ‘On Measures to Promote the Cultivation and Export of Medicinal Plants’ (with Annexes). Tashkent, 2020.

5.Presidential Decree No. PF-149 of 26 September 2024 ‘On measures to improve the management system in the field of ecology and environmental protection’ (with Annex 3). Tashkent, 2024.

6.A. Abduraimov, N. Yusupova, T. Makhkamov et al., "Medicinal plants of Uzbekistan’s arid zones," Plants (MDPI), 2023, doi: 10.3390/plants12.

7.CEIC Data, Uzbekistan Pharmaceutical and Medicinal Product Exports, CEIC Global Economic Data, 2021. [Online]. Available: www.ceicdata.com

8.Government Commission Minute No. 184, November 2024; World Bank, Uzbekistan Resilient Landscapes Restoration Project (RESILAND), Presidential Resolution No. PQ-140 of 27 March 2024.

9.Dentons, Uzbekistan Pharmaceutical Market Analysis, Tashkent: Dentons Law Firm Central Asia Practice Group, 2024.

10.National Medicinal Plants Board (NMPB), Ministry of AYUSH, Government of India, Annual Demand-Supply Survey Methodology; APEDA Annual Report 2022–2023.

11.L. Medina and F. Schneider, "Shadow economies around the world," IMF Working Paper WP/18/17, IMF, 2019; C. M. Peters, Sustainable Harvest of Non-Timber Plant Resources in Tropical Moist Forest, Biodiversity Support Program, 1994.

Downloads

Published

2026-09-22